196195-13-8

196195-13-8 structure
196195-13-8 structure

Name 4-[3-(4-chloro-6-methoxyquinazolin-7-yl)oxypropyl]morpholine
Synonyms Quinazoline,4-chloro-6-methoxy-7-[3-(4-morpholinyl)propoxy]
4-chloro-6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazoline
4chloro-6-methoxy-7-(3-morpholinopropoxy)quinazoline
Molecular Formula C16H20ClN3O3
Molecular Weight 337.80100
Exact Mass 337.11900
PSA 56.71000
LogP 2.33080

~87%

196195-13-8 structure

196195-13-8

Literature: AstraZeneca AB Patent: EP1119567 B1, 2005 ; Location in patent: Page/Page column 27 ;

~60%

196195-13-8 structure

196195-13-8

Literature: AstraZeneca AB Patent: US7235559 B1, 2007 ; US 7235559 B1

~%

Detail
Literature: Hennequin, Laurent Francois Andre; Ple, Patrick; Lambert, Christine Marie Paul Patent: US2004/34046 A1, 2004 ;

~%

196195-13-8 structure

196195-13-8

Literature: Ple, Patrick A.; Green, Tim P.; Hennequin, Laurent F.; Curwen, Jon; Fennell, Michael; Allen, Jack; Lambert-Van Der Brempt, Christine; Costello, Gerard Journal of Medicinal Chemistry, 2004 , vol. 47, # 4 p. 871 - 887

~%

196195-13-8 structure

196195-13-8

Literature: Ple, Patrick A.; Green, Tim P.; Hennequin, Laurent F.; Curwen, Jon; Fennell, Michael; Allen, Jack; Lambert-Van Der Brempt, Christine; Costello, Gerard Journal of Medicinal Chemistry, 2004 , vol. 47, # 4 p. 871 - 887

~%

196195-13-8 structure

196195-13-8

Literature: Cai, Jin; Sun, Min; Wu, Xiaoqing; Chen, Junqing; Wang, Peng; Zong, Xi; Ji, Min European Journal of Medicinal Chemistry, 2013 , vol. 63, p. 702 - 712